GGrantIndex
← Leaderboards

Ying Xia

University Of Cincinnati

$10,969,354
Attributed
$10,969,354
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $964.2K · FY200523
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$10,969,354 · 6

By mechanism

R01$9,336,374 · 3
R21$880,750 · 2
P30$752,230 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Cincinnati

Same institution · by research overlap

Others in their field

Top investigators on “Phenotype

Research focus

PhenotypeGeneticEmbryoSignal TransductionComplexMolecularGenesMorphogenesisDefectLeadProgramsBasePathway InteractionsAffectEyelid StructureEtiologyEventEnvironmental Risk FactorMediatingEpitheliumIn UteroEpithelial CellsInsightIn Vivo

Grant awards (33)

Gene-environment interactions in epithelial morphogenesis$454,928
R01 · FY2023 · HD · contact PI
Signaling mechanisms of gene-environment interactions in female reproductive$202,500
R21 · FY2023 · ES · contact PI
Gene-environment interactions in epithelial morphogenesis$454,928
R01 · FY2022 · HD · contact PI
Integrative Technologies Support Core$266,274
P30 · FY2022 · ES · contact PI
Signaling mechanisms of gene-environment interactions in female reproductive$243,000
R21 · FY2022 · ES · contact PI
Gene-environment interactions in epithelial morphogenesis$454,928
R01 · FY2021 · HD · contact PI
Integrative Technologies Support Core$219,682
P30 · FY2021 · ES · contact PI
Gene-environment interactions in epithelial morphogenesis$464,211
R01 · FY2020 · HD · contact PI
Integrative Technologies Support Core$266,274
P30 · FY2020 · ES · contact PI
Gene-environment interactions in epithelial morphogenesis$463,850
R01 · FY2019 · HD · contact PI
The Role of MAP 3 Kinase 1 in Ocular Surface Morphogenesis$395,000
R01 · FY2019 · EY · contact PI
The Role of MAP 3 Kinase 1 in Ocular Surface Morphogenesis$395,000
R01 · FY2018 · EY · contact PI
The Role of MAP 3 Kinase 1 in Ocular Surface Morphogenesis$395,000
R01 · FY2017 · EY · contact PI
The Role of MAP 3 Kinase 1 in Ocular Surface Morphogenesis$395,000
R01 · FY2016 · EY · contact PI
The Role of MAP 3 Kinase 1 in Ocular Surface Morphogenesis$395,729
R01 · FY2015 · EY · contact PI
Gene-Environment Interactions in Eyelid Morphogenesis$197,500
R21 · FY2015 · ES · contact PI
Gene-Environment Interactions in Eyelid Morphogenesis$237,750
R21 · FY2014 · ES · contact PI
The Role of MAP 3 kinase 1 in Ocular Surface Morphogenesis$357,252
R01 · FY2012 · EY · contact PI
The Role of MAP 3 kinase 1 in Ocular Surface Morphogenesis$358,673
R01 · FY2011 · EY · contact PI
The Role of MAP 3 kinase 1 in Ocular Surface Morphogenesis$84,780
R01 · FY2011 · EY · contact PI
The Role of MAP 3 kinase 1 in Ocular Surface Morphogenesis$374,931
R01 · FY2010 · EY · contact PI
The Role of MAP 3 kinase 1 in Ocular Surface Morphogenesis$379,802
R01 · FY2009 · EY · contact PI
The Role of MAP 3 kinase 1 in Ocular Surface Morphogenesis$204,500
R01 · FY2009 · EY · contact PI
Mechanism of MEK Kinase 1 in Mouse Eyelid Development$328,663
R01 · FY2008 · EY · contact PI
Mechanism of MEK Kinase 1 in Mouse Eyelid Development$335,371
R01 · FY2007 · EY · contact PI
Signaling Mechanisms of TCDD-induced AHR Activation$311,105
R01 · FY2007 · ES · contact PI
Mechanism of MEK Kinase 1 in Mouse Eyelid Development$337,259
R01 · FY2006 · EY · contact PI
Signaling Mechanisms of TCDD-induced AHR Activation$320,396
R01 · FY2006 · ES · contact PI
Mechanism of MEK Kinase 1 in Mouse Eyelid Development$345,375
R01 · FY2005 · EY
Signaling Mechanisms of TCDD-induced AHR Activation$328,106
R01 · FY2005 · ES
Mechanism of MEK Kinase 1 in Mouse Eyelid Development$345,375
R01 · FY2004 · EY
Signaling Mechanisms of TCDD-induced AHR Activation$328,106
R01 · FY2004 · ES
Signaling Mechanisms of TCDD-induced AHR Activation$328,106
R01 · FY2003 · ES